Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
abide, Ablation, Academy, AccuCEA, adenocarcinoma, AGA, al, altogether, Anthem, Arizona, array, ARUP, ATA, attended, atypia, atypical, auditor, Avenue, awaiting, banking, Belgium, biased, bile, bioinformatic, Black, British, broadest, Canadian, catastrophe, cellular, Century, CEP, chemotherapy, Chicago, CHIP, chosen, Cigna, CIO, Columbia, commentary, composite, conclusion, Conference, conflicted, conflicting, constraint, converge, convergence, Corrupt, COSO, currency, cybersecurity, Dakota, database, DDW, delegating, Digestive, discovered, discreet, downgrade, Dr, drop, dropping, duct, ductal, efficacy, eighty, embedded, Epithelium, erosion, Evicore, FCPA, feature, Felice, fell, fingerprint, flooding, Fukuoka, GPO, GX, heterozygosity, Horizon, IDGGW, illiquid, incompliance, inoperable, insist, internationally, Iowa, Italy, Kalorama, Lake, Lane, Liberty, licensor, lieu, LOH, lung, MACRA, magazine, malware, marker, McCormick, menu, metastatic, Microdissection, miRInform®in, miRInform®thyroid, Mucosa, multinational, neoplastic, nonemployee, Northeastern, Notwithstanding, NYS, NYSE, official, offshore, ofNASDAQcontinued, ofthe, oldest, onNASDAQ, OnOctober, oral, Orlando, ourPathFinderTG®platform, outbreak, oversee, Oxford, PancreaSeq, PathFinderTG®platform, payer, PCAOB, PCR, PDAC, pharma, pipeline, political, portal, precursor, predictor, premier, pressure, Pretreated, profile, pronouncement, prove, proximity, PTEN, purview, Quadax, questioning, qui, Radiofrequency, rationally, Realty, Reauthorization, recalculated, recurrence, recurrent, Regenerated, repaid, repatriated, repatriation, repository, reproducibility, respridx, revaluation, revalued, Reveal, SAB, Salt, SEER, Sequenomholding, short, Spain, steal, Switzerland, tam, TCJA, terrorism, TERT, theMayodecision, TheTCJA, theWorldwide, ThyGenX®test, ThyraMIR®by, ThyraMIR®for, ThyraMIR®molecular, ThyraMIR®test, tool, top, TP, triennial, uncollectable, uncompleted, undistributed, uneconomical, uninsured, UnitedHealthcare, unrest, USCAP, Utah, Vancouver, Victoria, Wang, War, WCOG, weather, Wellmark, whistleblower, widespread, worldwide, worth
Removed:
acquiring, aggregated, allocate, announcing, ascertain, ascribed, attack, bad, bankruptcy, Cadillac, chairman, challenging, clause, climate, considerably, constitutionality, continuity, controlled, default, deliver, excluding, execute, exit, federally, headcount, highest, impeding, improper, light, marketable, Mio, negotiating, occasion, origination, play, premium, realigned, reissued, relation, reviewing, rollforward, routine, routinely, satisfied, Secretary, slower, sought, Spring, staggered, stay, sweeping, SWK, tangible, targeted, teaching, terminal, thirty, transferring, unclear, voluntarily, wrote
Filing tables
Filing exhibits
Related press release
IDXG similar filings
Filing view
External links
EXHIBIT 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Interpace Diagnostics Group, Inc.
Parsippany, New Jersey
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-207263) and Form S-8 (No. 333-61231, 333-60512, 333-177969, 333-201070, and 333-214260) of Interpace Diagnostics Group, Inc. of our report dated March 22, 2018, relating to the consolidated financial statements and financial statement schedule, which appear in this Form 10-K.
/s/ BDO USA, LLP
Woodbridge, New Jersey
March 23, 2018